For Pharma & Biotech
Design inclusive clinical trials with the communities they intend to enroll, fulfill supplier diversity mandates, and partner with rare disease advocacy organizations — on a certified minority-owned collaboration platform.
Certified Minority-Owned Business — Qualifying for Pharma Supplier Diversity Programs
Your Challenges
-
Supplier diversity mandates requiring certified minority-owned partner engagement
-
FDA pressure to improve diversity and representation in clinical trial enrollment
-
Fragmented advocacy landscape making it hard to identify the right patient community partners
-
Real-world evidence gaps due to underrepresented populations in existing studies
Our Solutions
-
Direct access to a certified MBE platform qualifying under supplier diversity programs
-
Rare disease advocacy organizations ready to co-design trials with you — patient communities at the design table, not just the enrollment funnel
-
Community-engaged trial design support from consultants with clinical and advocacy backgrounds
-
Design-stage engagement with patient communities — trust built where trials begin, before protocols are locked
Frequently Asked Questions
- How does Elevate Impact support clinical trial diversity?
- We connect pharma teams with advocacy organizations, patient communities, and research partners to support inclusive trial design, recruitment, and community engagement — aligned with FDA diversity guidance.
- Does Elevate Impact qualify for supplier diversity programs?
- Yes. Elevate Impact is a certified Minority Business Enterprise (MBE) and Supplier Diversity Office certified partner, qualifying for pharma supplier diversity mandates.
